Focus: Dendreon is a biotechnology company specializing in autologous cell therapy and contract cell therapy manufacturing, headquartered in Seal Beach, California. The company focuses on gene therapy and cell therapy modalities with a concentrated pipeline in prostate cancer immunotherapy.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Dendreon offers a specialized cell therapy career with meaningful pipeline depth, but limited hiring and narrow indication focus present moderate stability risks for job seekers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dendreon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dendreon's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles